Quick Answer
Pharma-Bio Serv, Inc. reported Stockholders Equity of $11.91 million for fiscal year 2025.
Pharma-Bio Serv, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $11.91M | -13.1% |
| 2024 | $13.72M | -15.0% |
| 2023 | $16.13M | -2.6% |
| 2022 | $16.56M | -12.5% |
| 2021 | $18.91M | -16.7% |
| 2020 | $22.72M | +10.2% |
| 2019 | $20.61M | +1.7% |
| 2018 | $20.26M | -2.3% |
| 2017 | $20.75M | -4.9% |
| 2016 | $21.81M | -0.7% |
| 2015 | $21.96M | +7.1% |
| 2014 | $20.51M | +13.6% |
| 2013 | $18.05M | +40.2% |
| 2012 | $12.88M | +56.3% |
| 2011 | $8.24M | +62.5% |
| 2010 | $5.07M | +8.7% |
| 2009 | $4.66M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | $10.24M | -14.6% | -14.1% |
| October 31, 2025 | $11.91M | -13.1% | -0.1% |
| July 31, 2025 | $11.93M | -12.9% | -1.6% |
| April 30, 2025 | $12.12M | -13.1% | +1.1% |
| January 31, 2025 | $12.00M | -15.3% | -12.5% |
| October 31, 2024 | $13.72M | -15.0% | +0.2% |
| July 31, 2024 | $13.69M | -15.4% | -1.9% |
| April 30, 2024 | $13.95M | -11.0% | -1.4% |
- Pharma-Bio Serv, Inc. showed a decrease of -13.1% in Stockholders Equity compared to the prior fiscal year.
- Over the 2009–2025 period, Pharma-Bio Serv, Inc.’s stockholders equity has grown by 155.5% (from $4.66 million to $11.91 million).
- The most recent figure is from Pharma-Bio Serv, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on January 29, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: